Tufts University, Boston
L-carnitine for hemodialysis patients is associated with lower hospital use
Published in Pharma Investments, Ventures and Law Weekly, July 17th, 2005
According to a study from the United States, "Hospitalizations account for 41% of the total cost of end-stage renal disease (ESRD) care. Carnitine deficiency is common among dialysis patients, and some studies have shown improvements in anemia, and cardiac and skeletal muscle function upon administration of L-carnitine."
W.H. Kazmi and colleagues of Tufts University wrote, "We hypothesized that L carnitine may be associated with decreased hospital utilization in these patients. The Fresenius Medical Care North America dialysis database was used for this...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- Arrowhead Research Corporation
Nanotech company revises commercialization strategy - Arrowhead Research Corporation
Nanotechnology firm completes warrant redemption - BioVeris Corporation
Diagnostics company reports loss of $0.27 per share - Biophan Technologies, Inc.
Patent allowed for solution to enhance image quality of MRI - CV Therapeutics, Inc.
Biopharmaceutical firm reports option grants - Caraco Pharmaceutical Laboratories, Ltd.
Pharmaceutical company reports 27% increase in sales - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
